Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 20, 2022
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
[ Wed, Apr 20th 2022
] - WOPRAI
Tue, April 19, 2022
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
[ Tue, Apr 19th 2022
] - WOPRAI
Jeffrey Johnson Downgraded (XRAY) to Hold and Held Target at $48 on, Apr 19th, 2022
Jeffrey Johnson of Baird, Downgraded "DENTSPLY SIRONA Inc." (XRAY) to Hold and Held Target at $48 on, Apr 19th, 2022.
Jeffrey has made no other calls on XRAY in the last 4 months.
There are 4 other peers that have a rating on XRAY. Out of the 4 peers that are also analyzing XRAY, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $59 on, Tuesday, March 1st, 2022
These are the ratings of the 3 analyists that currently disagree with Jeffrey
- Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $67 on, Tuesday, March 1st, 2022
- Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $67 on, Friday, February 18th, 2022
- Erin Wright of "Morgan Stanley" Initiated at Buy and Held Target at $62 on, Monday, January 31st, 2022
